Vontobel Holding Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History

Vontobel Holding Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $153,356 - $222,147	5,477 New	5,477 $222,000
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $22,741 - $40,162	-574 Reduced 8.6%	6,104 $278,000
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $317,519 - $450,999	-5,466 Reduced 45.01%	6,678 $450,000
Q3 2021 Oct 29, 2021	BUY	$58.38 - $84.96 $173,446 - $252,416	2,971 Added 32.39%	12,144 $758,000
Q2 2021 Aug 06, 2021	SELL	$62.15 - $90.32 $94,903 - $137,918	-1,527 Reduced 14.27%	9,173 $760,000
Q1 2021 May 11, 2021	BUY	$61.35 - $90.47 $177,915 - $262,363	2,900 Added 37.18%	10,700 $710,000
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $341,796 - $665,886	7,800 New	7,800 $598,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.23B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.